Barry Smith Sells 700 Shares of The Ensign Group (NASDAQ:ENSG) Stock
Director Barry Smith sold 700 shares of The Ensign Group (NASDAQ:ENSG) stock for $137,655.00 on April 2nd, reducing his stake by 3.06% to 22,152 shares. This transaction was conducted under a pre-arranged Rule 10b5-1 plan. The company recently reported strong quarterly earnings, beating estimates with $1.82 EPS and 20.2% revenue growth, and provided optimistic FY2026 guidance, while analysts maintain a "Buy" rating with an average target of $204.60.
Smith Barry M sells $137k of Ensign Group (ENSG) stock
Director Barry M Smith sold 700 shares of Ensign Group (ENSG) common stock for $137,655 on April 2, 2026. This transaction was part of a Rule 10b5-1 trading plan. The sale occurred while ENSG was trading near $198, up 52% over the past year, although InvestingPro analysis suggests the stock might be overvalued.
Smith Barry M sells $137k of Ensign Group (ENSG) stock
Director Barry M Smith sold 700 shares of Ensign Group (ENSG) stock for a total of $137,655 on April 2, 2026, under a Rule 10b5-1 trading plan. This sale occurred while ENSG shares are up 52% over the past year but are considered overvalued. The company recently reported strong Q4 2025 earnings, leading Truist Securities to raise its price target for ENSG.
Ensign Group (ENSG) director sells 700 shares in planned 10b5-1 trade
Ensign Group director Barry M. Smith sold 700 shares of common stock at $196.65 per share on April 2, 2026, as part of a pre-arranged Rule 10b5-1 trading plan established on July 29, 2025. Following this transaction, Smith directly holds 22,152 shares. The sale amounted to approximately $138,000 and the filing sentiment was rated as moderately negative due to the insider sale.
Do Rising Earnings Estimates Reshape the Bull Case for Ensign Group’s High-Acuity Model (ENSG)?
Recent analyst updates highlight upward revisions to earnings estimates for Ensign Group (ENSG), reflecting improved expectations for its post-acute and senior care operations. This growing optimism, however, places a greater emphasis on the company's ability to execute on acquisitions, staffing, and integration, especially given its premium valuation. Investors are encouraged to conduct their own diligent research to weigh these factors, including the stock's fair value estimations.
Has Agenus (AGEN) Surpassed Other Healthcare Stocks So Far This Year?
Agenus (AGEN) has outperformed the broader Medical sector and its specific industry peers so far this year, with a 6.1% advance compared to the sector's 4.1% decline. The company holds a Zacks Rank of #1 (Strong Buy), driven by a significant 352.4% increase in its full-year earnings consensus estimate. Ensign Group (ENSG) is another strong performer in the Medical sector, having gained 12.9% year-to-date and holding a Zacks Rank of #2 (Buy).
Strong growth and governance focus in Ensign Group (NASDAQ: ENSG) 2026 proxy
Ensign Group's 2026 proxy statement details a strong 2025 performance, with consolidated revenue up 18.7% to $5.06 billion, highlighting operational improvements and consistent dividend increases. The company is seeking stockholder votes on director elections, auditor ratification, and executive pay, while emphasizing enhanced corporate governance, ESG initiatives, and robust risk oversight. Key financial figures and detailed compensation discussions are provided, along with information on related party transactions and equity compensation plans.
The Ensign Group Stock: A Steady Performer in Post-Acute Healthcare Services for North American Investors
The Ensign Group, Inc. operates skilled nursing and senior living facilities in the U.S. post-acute care sector, utilizing a decentralized model and a "buy-and-build" acquisition strategy. The company benefits from demographic tailwinds of an aging population and maintains financial resilience through vertical integration and solid balance sheets. Investors should monitor regulatory changes in Medicare funding and labor costs as potential risks, alongside the company's continuous focus on disciplined capital allocation and strategic growth.
Ensign Group (ENSG) is a Leading Growth Stock: Is It Worth Investing In?
The Ensign Group (ENSG) is highlighted as a leading growth stock with a Zacks Rank #2 (Buy) and a VGM Score of B, making it attractive for growth-oriented investors. The company provides healthcare services across various sectors and is projected to see a 13.9% increase in earnings for the current fiscal year. Analysts have raised future earnings estimates, and ENSG has a positive average earnings surprise, suggesting strong potential.
The Ensign Group, Inc. $ENSG Shares Bought by SG Americas Securities LLC
SG Americas Securities LLC significantly increased its stake in The Ensign Group (NASDAQ:ENSG) by 70.2%, now owning 38,029 shares valued at $6.63 million. Institutional investors collectively hold about 96.12% of the company's stock. The Ensign Group exceeded Q4 earnings expectations with an EPS of $1.82 and reported a 20.2% year-over-year revenue increase, with analysts maintaining a "Buy" rating and an average price target of $204.60.
The Ensign Group Inc (ENSG) Stock Price Quote Today & Current Price Chart
This article provides the current stock price quote and chart for The Ensign Group Inc (ENSG). It also mentions online trading with the Smart Investment App by Capital.com.
Hunter Perkins Capital Management LLC Has $4.41 Million Stock Holdings in The Ensign Group, Inc. $ENSG
Hunter Perkins Capital Management LLC reduced its stake in The Ensign Group by 20.8% in Q4 2025, holding 25,330 shares valued at $4.41 million. The Ensign Group has a consensus "Buy" rating from analysts with an average target price of $204.60, and insider selling has been observed, totaling $3.33 million over the past 90 days. Institutional investors own approximately 96.12% of the company's stock.
ENSG Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial analysis of Ensign Group Inc (ENSG), detailing its revenue breakdown, profitability margins, and a comparison with competitors. Medicaid is the largest revenue contributor at 38.7%, and the company reports a gross margin of 14.30% and a net margin of 7.02%. ENSG, with a market capitalization of $11.66B, is benchmarked against SOLV and GH, showing lower gross margins compared to its peers.
(ENSG) Movement Within Algorithmic Entry Frameworks
The Ensign Group Inc. (NASDAQ: ENSG) is showing neutral near and mid-term readings but maintains a long-term positive bias according to algorithmic analysis. A mid-channel oscillation pattern is noted, with a strong short setup presenting a 24.4:1 risk-reward ratio. The analysis provides specific entry, target, and stop-loss zones for long, breakout, and short positions, alongside multi-timeframe signal analysis.
Fort Washington Investment Advisors Inc. OH Raises Stock Holdings in The Ensign Group, Inc. $ENSG
Fort Washington Investment Advisors Inc. OH increased its stake in The Ensign Group, Inc. by 8.4% in the fourth quarter, bringing their total holdings to 163,131 shares valued at approximately $28.42 million. The Ensign Group (NASDAQ:ENSG) exceeded Q4 EPS expectations and reported a 20.2% year-over-year revenue increase, with analysts maintaining a "Buy" consensus rating and an average target price of $204.60. Despite insider sales totaling about $3.33 million and a quarterly dividend announced, institutional investors now own about 96.12% of the company's stock.
Riverbridge Partners LLC Has $121.33 Million Stock Holdings in The Ensign Group, Inc. $ENSG
Riverbridge Partners LLC reduced its stake in The Ensign Group, Inc. by 8.7% in Q4, but still holds 696,510 shares valued at $121.33 million, making it their 9th largest holding. Despite this reduction, Ensign Group reported strong Q4 earnings, beating analyst expectations with an EPS of $1.82 and a 20.2% year-over-year revenue increase. The company also provided optimistic FY2026 EPS guidance, and analysts maintain a consensus "Buy" rating with an average price target of $204.60.
Vanguard reports zero holdings in Ensign (NASDAQ: ENSG) after realignment
Vanguard has filed an amended Schedule 13G/A, reporting zero beneficial ownership of Ensign Group (NASDAQ: ENSG) common stock. This change is due to an internal realignment effective January 12, 2026, where Vanguard's subsidiaries will now report their holdings separately. This is an administrative reclassification, not a market trade, and clarifies that Vanguard itself no longer holds direct beneficial ownership of Ensign shares.
How Ensign’s EPS Beat and Revenue Miss Could Reshape the Ensign Group (ENSG) Investment Story
The Ensign Group (ENSG) recently reported an EPS beat and a revenue miss for the quarter, affirming a quarterly dividend. This indicates strong margin management and a focus on high-acuity care are driving consistent earnings despite a top-line revenue shortfall. The company's operational strength and growth through acquisitions are key drivers, while valuation and reimbursement pressures remain risks for investors.
The Ensign Group, Inc. (NASDAQ:ENSG) to Issue $0.07 Quarterly Dividend
The Ensign Group, Inc. (NASDAQ:ENSG) has declared a quarterly dividend of $0.065 per share, representing an annualized dividend of $0.26 and a 0.1% yield. The company has a strong track record of 18 consecutive years of dividend increases and a low payout ratio of 3.7%, indicating excellent earnings coverage. ENSG recently surpassed Q4 earnings estimates with $1.82 EPS and 20.2% revenue growth, and analysts maintain a "Buy" rating with a consensus price target of $204.60.
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share
The Ensign Group, Inc. announced a quarterly cash dividend of $0.0650 per share of common stock. This dividend will be payable on or before April 30, 2026, to shareholders of record as of March 31, 2026. Ensign has consistently paid dividends since 2002.
Ensign sets April 30 dividend payout for holders on record March 31
The Ensign Group (ENSG) has declared a quarterly cash dividend of $0.0650 per share, payable on or before April 30, 2026, to shareholders of record as of March 31, 2026. The company, which operates 378 healthcare facilities, has been consistently paying dividends since 2002. This announcement reinforces its long-standing commitment to returning value to shareholders.
The Ensign Group, Inc. (ENSG) Hit a 52 Week High, Can the Run Continue?
The Ensign Group, Inc. (ENSG) recently reached a 52-week high, raising questions about the sustainability of its stock performance. This milestone indicates strong momentum and investor confidence in the company. The article poses whether ENSG can maintain its upward trajectory.
Ensign Group at Oppenheimer Conference: Optimistic Growth Outlook By Investing.com
The Ensign Group (NASDAQ:ENSG) presented an optimistic growth outlook at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. The company projects a 15% revenue increase and a 14% EPS rise in 2026, driven by broad-based occupancy growth and strategic acquisitions. Ensign Group also emphasized its focus on operational excellence, regulatory adaptability, and expansion into new states like Florida and Georgia.
JPMorgan Chase & Co. Boosts Holdings in The Ensign Group, Inc. $ENSG
JPMorgan Chase & Co. significantly increased its stake in The Ensign Group, Inc. by 20.2% in the third quarter of 2025, now holding 433,600 shares valued at approximately $74.9 million. Other institutional investors like Baillie Gifford and Norges Bank also increased or initiated large positions, pushing overall institutional ownership to 96.12%. The Ensign Group reported strong Q3 earnings, beating EPS estimates and showing a 20.2% year-over-year revenue increase, with analysts maintaining a "Buy" consensus rating and an average price target of $204.60.
The Ensign Group, Inc. (ENSG) Hit a 52 Week High, Can the Run Continue?
This article discusses Ensign Group Inc. (ENSG) reaching a 52-week high, raising questions about the sustainability of its stock rally. It highlights factors that could influence future performance, such as current valuation and market sentiment. Investors are prompted to consider if the recent growth can be maintained.
The Ensign Group, Inc. (NASDAQ:ENSG) Given Average Rating of "Buy" by Analysts
The Ensign Group, Inc. (NASDAQ:ENSG) has received a consensus "Buy" rating from seven research firms, with an average 12-month price target of $204.60. The company recently exceeded quarterly EPS estimates, reported a 20.2% increase in revenue year-over-year, and set positive FY 2026 guidance. Insider transactions noted recent share sales by CFO Suzanne Snapper and Director Barry M. Smith, while institutional investors have been increasing their positions in ENSG.
How (ENSG) Movements Inform Risk Allocation Models
This article analyzes The Ensign Group Inc. (ENSG) using AI models to inform risk allocation. It highlights a neutral near and mid-term outlook with a long-term positive bias, noting support testing and a favorable risk-reward setup. Three trading strategies (Position, Momentum Breakout, and Risk Hedging) are presented for different risk profiles and holding periods, alongside multi-timeframe signal analysis.
Why Ensign Group (ENSG) is a top growth stock for the long term
This article from MSN focuses on why Ensign Group (ENSG) is considered a top growth stock for long-term investment. It likely discusses the company's financial performance, market position, and future growth prospects to support this assertion.
Assessing Ensign Group (ENSG) Valuation After Strong Multi‑Period Share Price Momentum
Ensign Group (ENSG) has seen strong share price momentum over the past year, but its current valuation, with a P/E of 35.1x and discounted cash flow analysis, suggests it is overvalued compared to its peers and intrinsic value. Investors are currently paying a premium for its earnings profile, indicating that future growth is already priced in. The article suggests caution for investors due to this stretched valuation, advising them to review risks and explore other investment opportunities.
LRT Capital Management LLC Has $2.45 Million Position in The Ensign Group, Inc. $ENSG
LRT Capital Management LLC significantly increased its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 76.7% in Q3, now holding 14,167 shares valued at $2.45 million. The Ensign Group has a "Buy" consensus rating from analysts with an average price target of $204.60, and recently reported strong quarterly earnings, beating estimates and increasing its dividend. Insider selling activity was also noted, with key executives reducing their holdings.
Assessing Ensign Group (ENSG) Valuation After Strong Multi‑Period Share Price Momentum
Ensign Group (ENSG) has seen strong share price momentum over the past year but its current valuation, with a P/E of 35.1x and discounted cash flow analysis, suggests it is overvalued. The stock trades at a significant premium compared to its peers and the healthcare industry average. Investors should consider these valuation concerns and potential risks despite recent growth in revenue and net income.
Hound Partners LLC Takes $12.06 Million Position in The Ensign Group, Inc. $ENSG
Hound Partners LLC recently acquired a new position in The Ensign Group, Inc. (NASDAQ:ENSG) during the third quarter, purchasing 69,801 shares valued at approximately $12.06 million, making it their 17th largest holding. Other institutional investors have also adjusted their stakes in ENSG, which currently has a market capitalization of $12.15 billion and a P/E ratio of 35.91. The Ensign Group posted strong quarterly earnings, beating analyst estimates, increased its dividend, and received several "Buy" ratings from analysts, with a consensus target price of $204.60.
Bard Associates Inc. Decreases Holdings in The Ensign Group, Inc. $ENSG
Bard Associates Inc. significantly reduced its holdings in The Ensign Group, Inc. (ENSG) by 37.1% in Q3, selling 31,513 shares and now owning 53,480 shares valued at approximately $9.24 million. Despite this, other institutional investors increased their stakes, and analysts maintain a consensus "Buy" rating with an average price target of $204.60. The Ensign Group reported strong Q4 earnings, beating EPS estimates, and increased its quarterly dividend.
The Ensign Group, Inc. $ENSG Shares Acquired by Clark Capital Management Group Inc.
Clark Capital Management Group Inc. increased its stake in The Ensign Group (NASDAQ:ENSG) by 3.9% in the third quarter, now owning 498,529 shares valued at $86.13 million. Institutional investors collectively hold 96.12% of the company's stock. The Ensign Group posted strong Q3 results, beating EPS estimates and growing revenue by 20.2%, and analysts have a "Buy" rating with an average target price of $204.60.
The Ensign Group to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026
The Ensign Group, Inc. announced its participation in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026. Key executives, including CEO Barry Port, CFO Suzanne Snapper, and CIO Chad Keetch, will present on the company's operations and growth strategy. A live webcast of the presentation will be available, with an archived version accessible for 90 days.
The Ensign Group to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026
The Ensign Group, Inc. (Nasdaq: ENSG) announced its participation in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026. Key executives, including CEO Barry Port and CFO Suzanne Snapper, will present on the company's operations, growth strategy, and related information at 10:40 a.m. Eastern Time. A live webcast of the presentation will be available and archived for 90 days.
The Ensign Group to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026
The Ensign Group, Inc. announced its participation in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026. Key executives, including CEO Barry Port and CFO Suzanne Snapper, will present on the company's operations and growth strategy at 10:40 a.m. Eastern Time. A live webcast of the presentation will be available online and archived for 90 days.
Senior operator Ensign Group to discuss growth strategy at Oppenheimer event
The Ensign Group (NASDAQ: ENSG) is scheduled to present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026, at 10:40 a.m. Eastern Time. Key executives including CEO Barry Port will discuss the company's operations, growth strategy, and related information, with a live webcast and archived replay available for 90 days. The announcement comes after the company reported strong 2025 financial results and expanded its portfolio to 378 healthcare facilities across 17 states through recent acquisitions.
The Ensign Group to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026
The Ensign Group, Inc. (Nasdaq: ENSG) announced its participation in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026. Key executives, including CEO Barry Port, will present on the company's operations, growth strategy, and related information. A live webcast of the presentation will be available, and an archived version will be accessible for 90 days.
Barclays PLC Boosts Stock Position in The Ensign Group, Inc. $ENSG
Barclays PLC increased its stake in The Ensign Group, Inc. by 6.6% in the third quarter, now owning 136,240 shares valued at $23.54 million. Other institutional investors have also adjusted their positions, and Ensign Group recently reported strong earnings, exceeding consensus estimates. The company also increased its quarterly dividend and has seen some insider selling activity, while analysts largely maintain a "Buy" rating on the stock.
Ensign Group ‘thrilled’ to buy 5 SNFs located in AZ, TX, WI
Ensign Group, through its real estate company Standard Bearer Healthcare REIT, has acquired five skilled nursing facilities (SNFs) across Arizona, Texas, and Wisconsin. CEO Barry Port expressed excitement about expanding their portfolio, particularly highlighting growth in Arizona by adding a 225-bed facility and bolstering their presence in mature markets like Texas with three more facilities. The acquisitions also include a SNF in Wisconsin, building on previous expansions in the state, with operations leased to Ensign-affiliated operators.
The Ensign Group, Inc. $ENSG Shares Sold by First Trust Advisors LP
First Trust Advisors LP reduced its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 20.8% in the third quarter. Despite this, other institutional investors increased their positions, and analysts have issued "Buy" and "Strong Buy" ratings with an average price target of $204.60. The company reported strong quarterly earnings, increased its dividend, and saw some insider selling activity.
The Ensign Group buys skilled nursing facility in Texas and Idaho
The Ensign Group has acquired two skilled nursing facilities, expanding its portfolio in Texas and Idaho. These strategic acquisitions aim to strengthen Ensign's presence and operational capabilities in these key markets.
Trading Systems Reacting to (ENSG) Volatility
The Ensign Group Inc. (NASDAQ: ENSG) is experiencing volatility with weak near-term sentiment potentially challenging long-term strength. AI models have generated three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—each with specific entry/target/stop-loss points. The analysis highlights a mid-channel oscillation pattern and offers an exceptional short setup.
Here’s the Reason Investors Are Turning to Ensign Group Shares Right Now
Ensign Group (ENSG) is positioned for continued growth due to strategic acquisitions, operational enhancements, and investments in healthcare facilities across 17 states. Analysts project a 13.9% increase in earnings per share for 2026, with revenue growth driven by expanding service offerings and an aging U.S. population. The company's strong financial approach, including consistent dividend payments and low debt, further supports its positive outlook, though rising operating expenses and a high valuation present potential risks.
Why Has Ensign Group (ENSG) Gained 5.1% Following Its Most Recent Earnings Announcement?
Ensign Group (ENSG) experienced a 5.1% stock increase following its recent earnings announcement, outperforming the S&P 500. The company reported strong Q4 2025 results, with adjusted EPS exceeding expectations by 4% and revenue climbing 20.2% year-over-year, driven by improved occupancy rates. Analysts project continued growth, with higher forecasts for 2026 revenues and adjusted EPS, leading to a Zacks Rank #2 (Buy) rating.
Ensign Group (ENSG) CIO awarded 20,000 options and 8,000 shares
Ensign Group's CIO, Chad Keetch, was granted 20,000 Employee Stock Options and 8,000 shares of common stock as part of a compensation award. These equity awards, which are not market purchases, will vest in five equal annual installments starting February 26, 2027. Following these grants, Keetch now directly owns 110,754 shares of common stock and holds 20,000 stock options.
Victory Capital Management Inc. Acquires 339,534 Shares of The Ensign Group, Inc. $ENSG
Victory Capital Management Inc. significantly increased its stake in The Ensign Group, Inc. (NASDAQ:ENSG) during the third quarter, purchasing an additional 339,534 shares. This acquisition boosts their total holdings to 513,328 shares, representing approximately 0.89% of the company, valued at $88.7 million. The Ensign Group has received positive analyst ratings, featuring a consensus "Buy" rating and a price target of $204.60, alongside strong Q4 earnings and increased dividend payments.
Is Ensign Group’s Consistent Earnings Outperformance Reshaping the Investment Case for ENSG?
Ensign Group (ENSG) recently exceeded quarterly profit expectations, reinforcing an investment narrative based on consistent operational execution despite revenue slightly missing forecasts. This strong performance and positive 2026 guidance support its current valuation, although the stock trades above some fair value estimates. Investors should weigh the high expectations against the company's solid profitability and consistent earnings beats.
American Century Companies Inc. Decreases Stake in The Ensign Group, Inc. $ENSG
American Century Companies Inc. reduced its holdings in The Ensign Group, Inc. by 11.3% in the third quarter, now owning 545,130 shares valued at approximately $94.18 million. Despite this decrease, other hedge funds increased their stakes, and institutional investors own a significant 96.12% of the company's stock. The Ensign Group reported strong Q3 earnings, beating analyst estimates, and has seen several analysts issue "Buy" ratings with an average target price of $204.60.
